MCK (STOCKS)
McKesson Corporation
$778.500000
-5.550000 (-0.71%)
Prev close: $784.050000
Company Information
- Exchange
- XNYS
- Sector
- Distribution Services
- Industry
- Medical Distributors
- CEO
- Brian Scott Tyler
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $93,766.98M
- Employees
- 51,000
- P/E (TTM)
- 20.43
- P/B (TTM)
- -43.32
- Dividend Yield
- 40.43%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
11
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q4)
|
$11.69 | $11.68 | +0.0136 | +0.12% |
|
Dec 2025 (Q3)
|
$9.34 | $9.31 | +0.0308 | +0.33% |
|
Sep 2025 (Q2)
|
$9.86 | $9.13 | +0.7305 | +8.00% |
|
Jun 2025 (Q1)
|
$8.26 | $8.23 | +0.0320 | +0.39% |
Financial Statements
| Revenues | $403.43B |
| Benefits Costs and Expenses | $397.23B |
| Cost Of Revenue | $388.88B |
| Costs And Expenses | $397.23B |
| Gross Profit | $14.55B |
| Nonoperating Income/Loss | $236.00M |
| Operating Expenses | $8.34B |
| Selling, General, and Administrative Expenses | $8.10B |
| Depreciation and Amortization | $729.00M |
| Operating Income/Loss | $6.21B |
| Income/Loss Before Equity Method Investments | $6.19B |
| Income/Loss From Continuing Operations After Tax | $5.10B |
| Income/Loss From Continuing Operations Before Tax | $6.20B |
| Income/Loss From Equity Method Investments | $7.00M |
| Income Tax Expense/Benefit | $1.10B |
| Income Tax Expense/Benefit, Current | $872.00M |
| Income Tax Expense/Benefit, Deferred | $230.00M |
| Net Income/Loss | $5.10B |
| Net Income/Loss Attributable To Noncontrolling Interest | $337.00M |
| Net Income/Loss Attributable To Parent | $4.76B |
| Net Income/Loss Available To Common Stockholders, Basic | $4.76B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $38.55 |
| Diluted Earnings Per Share | $38.38 |
| Basic Average Shares | 123,600,000 |
| Diluted Average Shares | 124,100,000 |
| Assets | $82.32B |
| Current Assets | $57.21B |
| Accounts Receivable | $27.99B |
| Inventory | $24.21B |
| Other Current Assets | $5.02B |
| Noncurrent Assets | $25.11B |
| Fixed Assets | $2.67B |
| Other Non-current Assets | $22.45B |
| Liabilities | $84.10B |
| Current Liabilities | $67.02B |
| Accounts Payable | $59.97B |
| Other Current Liabilities | $7.04B |
| Noncurrent Liabilities | $17.08B |
| Long-term Debt | $6.53B |
| Other Non-current Liabilities | $10.56B |
| Redeemable Noncontrolling Interest | $943.00M |
| Redeemable Noncontrolling Interest, Common | $943.00M |
| Equity | -$1.78B |
| Equity Attributable To Noncontrolling Interest | $395.00M |
| Equity Attributable To Parent | -$2.17B |
| Temporary Equity | $943.00M |
| Liabilities And Equity | $82.32B |
| Net Cash Flow From Operating Activities | $6.16B |
| Net Cash Flow From Operating Activities, Continuing | $6.16B |
| Net Cash Flow From Investing Activities | -$3.43B |
| Net Cash Flow From Investing Activities, Continuing | -$3.43B |
| Net Cash Flow From Financing Activities | -$4.63B |
| Net Cash Flow From Financing Activities, Continuing | -$4.63B |
| Exchange Gains/Losses | $20.00M |
| Net Cash Flow | -$1.89B |
| Net Cash Flow, Continuing | -$1.91B |
| Comprehensive Income/Loss | $5.29B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $337.00M |
| Comprehensive Income/Loss Attributable To Parent | $4.95B |
| Other Comprehensive Income/Loss | $187.00M |